Twist Bioscience (TWST) Gains from Investment Securities (2017 - 2018)
Twist Bioscience's (TWST) quarterly Gains from Investment Securities came in at -$79000.0 in Q3 2018, down 495.0% quarter-over-quarter from $20000.0 in Q2 2018.
Powered by 
Analysis
Twist Bioscience (TWST) Gains from Investment Securities (2017 - 2018) Analysis & Trends
Twist Bioscience (TWST) has reported Gains from Investment Securities for 2 consecutive years, with -$79000.0 the latest figure, recorded in Q3 2018.
- On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to -$79000.0 in Q3 2018; TTM through Sep 2018 was -$13000.0, a N/A change from a year earlier, with the FY2023 full-year figure at -$5.9 million, changed N/A from the prior year.
- Gains from Investment Securities was -$79000.0 for Q3 2018 at Twist Bioscience, down from $20000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $48000.0 in Q1 2018 and troughed at -$79000.0 in Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Twist Bioscience | 8.93 Bn | 8.76 Bn | 62.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | -79,000.00 |
| Jun 30, 2018 | 20,000.00 |
| Mar 31, 2018 | 48,000.00 |
| Dec 31, 2017 | -2,000.00 |